Tcwp LLC Bristol Myers Squibb CO Transaction History

Tcwp LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $4.25 Million - $4.76 Million	-73,484 Reduced 82.22%	15,891 $922,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $4.52 Million - $5.02 Million	70,925 Added 384.42%	89,375 $5.72 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $783,197 - $888,323	11,919 Added 182.5%	18,450 $1.28 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $101,144 - $119,769	-1,477 Reduced 18.44%	6,531 $469,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $32 - $18,979	247 Added 3.18%	8,008 $569,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $85,110 - $93,736	1,172 Added 17.79%	7,761 $597,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $4.51 Million - $5.41 Million	-73,398 Reduced 91.76%	6,589 $481,000
Q4 2021 Jun 13, 2022	BUY	$53.63 - $62.52 $4.29 Million - $5 Million	79,987 New	79,987 $4.99 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tcwp LLC, based on Form 13F filings with the SEC.

Stay updated on Tcwp LLC with notifications on news.